Neuroprotective effect of curcumin against oxidative damage in BV-2 microglia and high intraocular pressure animal model

Journal of Ocular Pharmacology and Therapeutics

Volumn 30, Issue 8, 2014, Pages 657-664

  Yue, Yan Kun ^a   Mo, Bin ^b   Zhao, Jun ^c   Yu, Ya Jie ^b   Liu, Lu ^b   Yue, Chang Li ^b   Liu, Wu ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c LINYI PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CURCUMIN; CYTOCHROME C; HYDROGEN PEROXIDE; PROTEIN BAX; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL COUNT; CELL SURVIVAL; CELL VIABILITY; CYTOTOXICITY TEST; DATA ANALYSIS SOFTWARE; DOWN REGULATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GLAUCOMA; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SPACE; INTRAOCULAR PRESSURE; MICROGLIA; MTT ASSAY; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; RAT; RAT MODEL; RETINA GANGLION CELL; UPREGULATION; WESTERN BLOTTING; WISTAR RAT; ANIMAL; CELL LINE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; OCULAR HYPERTENSION; PATHOLOGY;

ANIMALS; APOPTOSIS; CELL LINE; CELL SURVIVAL; CURCUMIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLOW CYTOMETRY; HUMANS; INTRAOCULAR PRESSURE; MICROGLIA; NEUROPROTECTIVE AGENTS; OCULAR HYPERTENSION; OXIDATIVE STRESS; RATS, WISTAR; REACTIVE OXYGEN SPECIES;

EID: 84912026274     PISSN: 10807683     EISSN: 15577732     Source Type: Journal    
DOI: 10.1089/jop.2014.0022     Document Type: Article

References (35)

1. Quigley, H.A., and Broman, A.T. The number of people with glaucoma worldwide in 2010 and 2020. Br. J. Oph-thalmol. 90:262-267, 2006.
2. Quigley, H.A. Open-angle glaucoma. N. Engl. J. Med. 328:1097-1106, 1993.
3. Neufeld, A.H., and Liu, B. Glaucomatous optic neuropathy: when glia misbehave. Neuroscientist. 9:485-495, 2003.
4. Tezel, G., and Wax, M.B. Glial modulation of retinal ganglion cell death in glaucoma. J. Glaucoma. 12:63-68, 2003.
5. Garcia-Valenzuela, E., Shareef, S., Walsh, J., and Sharma, S.C. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp. Eye Res. 61:33-44, 1995.
6. Morgan, W.H., and House, P. Relationship between intraocular pressure and glaucomatous optic neuropathy. Clin. Exp. Ophthalmol. 31:167-168, 2003; author reply 168-171.
7. Schraufstatter, E., and Bernt, H. Antibacterial action of curcumin and related compounds. Nature. 164:456, 1949.
8. Agrawal, D.K., and Mishra, P.K. Curcumin and its analogues: potential anticancer agents. Med. Res. Rev. 30:818-860, 2010.
9. Gupta, S.C., Prasad, S., Kim, J.H., Patchva, S., Webb, L.J., Priyadarsini, I.K., and Aggarwal, B.B. Multitargeting by curcumin as revealed by molecular interaction studies. Nat. Prod. Rep. 28:1937-1955, 2011.
10. Aggarwal, B.B., and Sung, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol. Sci. 30:85-94, 2009.
11. Pescosolido, N., Giannotti, R., Plateroti, A.M., Pascarella, A., and Nebbioso, M. Curcumin: therapeutical potential in ophthalmology. Planta Med. 80:249-254, 2014.
12. Ma, Q.L., Zuo, X., Yang, F., Ubeda, O., Gant, D., Alaverdyan, M., Teng, E., Hu, S., Chen, P.P., Maiti, P., Teter, B., Cole, G.M., and Frautschy, S.A. Curcumin suppresses soluble tau oligomers and corrects molecular chaperone, synaptic and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem. 288:4056-4065, 2013.
13. Lazar, A.N., Mourtas, S., Youssef, I., Parizot, C., Dauphin, A., Delatour, B., Antimisiaris, S.G., and Duyckaerts, C. Curcumin-conjugated nanoliposomes with high affinity for Abeta deposits: possible applications to Alzheimer disease. Nanomedicine. 9:712-721, 2013.
14. Aggarwal, B.B. Targeting inflammation-induced obesity and metabolic diseases by curcumin and other nu-traceuticals. Annu. Rev. Nutr. 30:173-199, 2010.
15. Saragovi, H.U., Hamel, E., and Di Polo, A. A neurotrophic rationale for the therapy of neurodegenerative disorders. Curr. Alzheimer Res. 6:419-423, 2009.
16. Yan, L., Liu, S., Wang, C., Wang, F., Song, Y., Yan, N., Xi, S., Liu, Z., and Sun, G. JNK and NADPH oxidase involved in fluoride-induced oxidative stress in BV-2 microglia cells. Mediators Inflamm. 2013:895975, 2013.
17. Chen, M., Liu, B., Gao, Q., Zhuo, Y., and Ge, J. Mitochondria-targeted peptide MTP-131 alleviates mitochon-drial dysfunction and oxidative damage in human trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 52:7027-7037, 2011.
18. Bai, Y.J., Huang, L.Z., Xu, X.L., Du, W., Zhou, A.Y., Yu, W.Z., and Li, X.X. Polyethylene glycol-modified pigment epithelial-derived factor: new prospects for treatment of retinal neovascularization. J. Pharmacol. Exp. Ther. 342:131-139, 2012.
19. Shareef, S.R., Garcia-Valenzuela, E., Salierno, A., Walsh, J., and Sharma, S.C. Chronic ocular hypertension following episcleral venous occlusion in rats. Exp. Eye Res. 61:379-382, 1995.
20. Wu, A., Ying, Z., and Gomez-Pinilla, F. Dietary curcumin counteracts the outcome of traumatic brain injury on oxi-dative stress, synaptic plasticity, and cognition. Exp. Neu-rol. 197:309-317, 2006.
21. Bai, Y., Dergham, P., Nedev, H., Xu, J., Galan, A., Rivera, J.C., ZhiHua, S., Mehta, H.M., Woo, S.B., Sarunic, M.V., Neet, K.E., and Saragovi, H.U. Chronic and acute models of retinal neurodegeneration TrkA activity are neuropro-tective whereas p75NTR activity is neurotoxic through a paracrine mechanism. J. Biol. Chem. 285:39392-39400, 2010.
22. Kwon, Y.H., Fingert, J.H., Kuehn, M.H., and Alward, W.L. Primary open-angle glaucoma. N. Engl. J. Med. 360:1113-1124, 2009.
23. Weinreb, R.N., and Khaw, P.T. Primary open-angle glaucoma. Lancet. 363:1711-1720, 2004.
24. Fan, B.J., and Wiggs, J.L. Glaucoma: genes, phenotypes, and new directions for therapy. J. Clin. invest. 120:3064-3072, 2010.
25. Dreyer, E.B., and Lipton, S.A. New perspectives on glaucoma. JAMA. 281:306-308, 1999.
26. Toda, N., and Nakanishi-Toda, M. Nitric oxide: ocular blood flow, glaucoma, and diabetic retinopathy. Prog. Re-tin. Eye Res. 26:205-238, 2007.
27. Lambeth, J.D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4:181-189, 2004.
28. Lieber, M.R., and Karanjawala, Z.E. Ageing, repetitive genomes and DNA damage. Nat. Rev. Mol. Cell Biol. 5:69-75, 2004.
29. Zhong, Y.S., Leung, C.K., and Pang, C.P. Glial cells and glaucomatous neuropathy. Chin. Med. J. (Engl.). 120:326-335, 2007.
30. Newmeyer, D.D., and Ferguson-Miller, S. Mitochondria: releasing power for life and unleashing the machineries of death. Cell. 112:481-490, 2003.
31. Frautschy, S.A., Hu, W., Kim, P., Miller, S.A., Chu, T., Harris-White, M.E., and Cole, G.M. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging. 22: 993-1005, 2001.
32. Bala, K., Tripathy, B.C., and Sharma, D. Neuroprotective and anti-ageing effects of curcumin in aged rat brain regions. Biogerontology. 7:81-89, 2006.
33. Ravindran, J., Prasad, S., and Aggarwal, B.B. Curcumin and cancer cells: how many ways can curry kill tumor cells selectively? AAPS J. 11:495-510, 2009.
34. Appendino, G., Belcaro, G., Cornelli, U., Luzzi, R., Togni, S., Dugall, M., Cesarone, M.R., Feragalli, B., Ippolito, E., Errichi, B.M., Pellegrini, L., Ledda, A., Ricci, A., Bavera, P., Hosoi, M., Stuard, S., Corsi, M., Errichi, S., and Gizzi, G. Potential role of curcumin phytosome (Meriva) in controlling the evolution of diabetic microangiopathy. A pilot study. Panminerva Med. 53:43-49, 2011.
35. Howells, L.M., Sale, S., Sriramareddy, S.N., Irving, G.R., Jones, D.J., Ottley, C.J., Pearson, D.G., Mann, C.D., Manson, M.M., Berry, D.P., Gescher, A., Steward, W.P., and Brown, K. Curcumin ameliorates oxaliplatin-induced chemoresistance in HCT116 colorectal cancer cells in vitro and in vivo. Int. J. Cancer 129:476-486, 2011.